Application of poria cortex triterpenoids in the preparation of medicines for treating nephropathy
The technology of Poria cocos skin and kidney disease is applied in the application field of Poria cocos triterpenoids in the preparation of medicines for treating kidney disease, which can solve the problem of high toxicity of traditional Chinese medicine extracts, and achieve the effects of reducing urine protein content and reducing the degree of lesions.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] 实施例1 茯苓皮三萜的提取制备。
[0025] (1)将茯苓皮用质量分数为1.5%的盐酸冲洗,然后用水冲洗至中性,晾干;
[0026] (2)将茯苓皮用体积分数为70%的乙醇溶液回流提取2次,每次提取时间为0.5h,茯苓皮与乙醇溶液的用量为1:10(g / ml),合并提取液,提取液回收乙醇至干;
[0027] (3)将步骤(1)的干物质用水溶解成溶液,加入体积比为7:1.5的正丁醇和乙酸乙酯的混合物萃取,正丁醇和乙酸乙酯的混合物的体积为水溶液的2倍,有机相回收溶剂至干,得粗品;
[0028] (4)粗品用100-120质量倍的乙醇溶解,配成溶液,所得溶液上中性氧化铝层析柱,中性氧化铝的质量为粗品的15倍,然后用乙醇和乙酸乙酯体积比为2:5的混合物进行洗脱,乙醇和乙酸乙酯混合物的用量为氧化铝的2倍,收集洗脱液;
[0029] (5)向洗脱液中加入活性炭,活性炭用量为粗品质量的3%,加热至沸腾并保持30min,趁热过滤,用乙醇洗涤活性炭,合并滤液及洗液,浓缩至原体积的1 / 3,静置沉淀、过滤、干燥,得茯苓皮三萜。
Embodiment 2
[0030] 实施例2 茯苓皮三萜中有效成分的测定。
[0031] 对提取物中羟基-羊毛甾7,9(11),24-三烯-21-酸和去氢依布里酸的含量进行测定,方法如下:
[0032] 仪器及试药:Waters高效液相色谱系统,Water600泵,996二极管阵列检测器,M32色谱工作站,Lichrospher-C18柱,200×4.6mm,5μ(江苏汉邦科技有限公司产品)。
[0033] 试剂:乙腈(色谱纯级),3β-羟基-羊毛甾7,9(11),24-三烯-21-酸和去氢依布里酸(山东省中药新型制剂中心制备,含量均达98.0 %above).
[0034] 检测条件:流动相:乙腈:0.5%乙酸水(80:20),检测波长242nm。
[0035] 对照品溶液的制备:精密称取3β-羟基-7,9(11),24-三烯-21-酸对照品,置10mL容量瓶中,甲醇稀释至刻度,制成228μg·mL -1 的对照品溶液;精密称取去氢依布里酸对照品,置10mL容量瓶中,甲醇稀释至刻度,制成130μg·mL -1 的对照品溶液。
[0036] 供试品溶液的制备:取实施例1中茯苓皮三萜约40mg,精密称定,置100mL容量瓶中,甲醇溶解并稀释至刻度,摇匀,用0.45μm的微孔滤膜过滤,取滤液,即得。
[0037] Determination method: Precisely draw 10 μL each of the above-mentioned reference substance solution and the test solution, and inject them into the liquid chromatograph respectively to obtain the chromatogram of the reference substance. figure 1 and extract chromatography figure 2 . According to peak area calculation, the content of 3β-hydroxy-lanoster 7,9(11), 24-triene-21-acid is 30.15%, the content of dehydroi...
Embodiment 3
[0038] Example 3 The efficacy of triterpenoids of poria cocos on doxorubicin nephrotic syndrome in rats.
[0039] 1 Materials and methods
[0040] 1.1 Instruments and medicines
[0041] WFZ UV-PC ultraviolet spectrophotometer (Unocal (Shanghai) Instrument Co., Ltd.); DXL-DL metabolic cage: Jiangsu Feng's Experimental Animal Equipment Co., Ltd.; calf serum albumin: Xi'an Walson Biotechnology Co., Ltd. Company; Coomassie Brilliant Blue G-250: China Pharmaceutical Group Shanghai Chemical Reagent Company; urine protein test paper: Guangdong Huadu Gaoerbao Biotechnology Co., Ltd.; doxorubicin hydrochloride: Zhejiang Hisun Pharmaceutical Co., Ltd., 10mg / bottle , batch number 130201, when used as a solvent, inject physiological saline as a solvent, and prepare a 2mg / ml solution; Poria cocos triterpenes use the sample in Example 1, and use olive oil as a solvent, and prepare a 10 mg / ml solution.
[0042] 1.2 Animals
[0043] Select healthy male Wistar rats, weighing 158 ± 13g, prov...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com